Paralleled comparison of vectors for the generation of CAR-T cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Paralleled comparison of vectors for the generation of CAR-T cells

Published:2016-09 Issue:8 Volume:27 Page:711-722
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Qin Di-Yuan,Huang Yong,Li Dan,Wang Yong-Sheng,Wang Wei,Wei Yu-Quan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference58 articles.

1. Efficacy and toxicity management of 19-28z CAR-T cell therapy in B cell acute lymphoblastic leukemia;Davila;Sci Transl Med,2014

2. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial;Lee;Lancet,2015

3. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N Engl J Med,2014

4. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor;Kochenderfer;J Clin Oncol,2015

5. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity;Gross;Proc Natl Acad Sci USA,1989

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in CAR‐Engineered Immune Cell Generation: Engineering Approaches and Sourcing Strategies;Advanced Science;2023-10-31

2. The efficacy and safety of chimeric antigen receptor T cells in digestive system cancers: a systematic review and meta-analysis;Annals of Translational Medicine;2022-05

3. Generation of CAR-T cells using lentiviral vectors;Methods in Cell Biology;2022

4. Delivery strategies for ex vivo and in vivo T-cell reprogramming;Systemic Drug Delivery Strategies;2022

5. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VIII: CAR-T cells: preclinical development - Safety and efficacy evaluation;Hematology, Transfusion and Cell Therapy;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3